Prognostic value of serum osteopontin in hepatocellular carcinoma patients treated with transarterial chemoembolization
Korean J Hepatol. 2009;15(3):320-330. Published online 2009 Sep 30 DOI: https://doi.org/10.3350/kjhep.2009.15.3.320
|
Citations to this article as recorded by
A radiomics signature associated with underlying gene expression pattern for the prediction of prognosis and treatment response in hepatocellular carcinoma
Dandan Wang, Linhan Zhang, Zhongqi Sun, Huijie Jiang, Jinfeng Zhang
European Journal of Radiology.2023; 167: 111086. CrossRef Tumor Biomarkers and Interventional Oncology: Impact on Local Outcomes for Liver and Lung Malignancy
Yuan-Mao Lin, Ryosuke Taiji, Marco Calandri, Bruno C. Odisio
Current Oncology Reports.2021;[Epub] CrossRef Prognostic Value of Serum Apolipoprotein B to Apolipoprotein A-I Ratio in Hepatocellular Carcinoma Patients Treated with Transcatheter Arterial Chemoembolization: A Propensity Score-Matched Analysis
Meng-Meng Liu, Zhan-Hong Chen, Li-Yun Zhao, Jing-Yuan Zhao, Dai-Lin Rong, Xiao-Kun Ma, Dan-Yun Ruan, Jin-Xiang Lin, Jing-Jing Qi, Pei-Shan Hu, Jing-Yun Wen, Jie Chen, Qu Lin, Xiang-Yuan Wu, Li Wei, Min Dong
Oncology Research and Treatment.2021; 44(9): 450. CrossRef ARD1/NAA10 in hepatocellular carcinoma: pathways and clinical implications
Danbi Lee, Myoung-Kuk Jang, Ji Hae Seo, Soo Hyung Ryu, Jeong A. Kim, Young-Hwa Chung
Experimental & Molecular Medicine.2018; 50(7): 1. CrossRef Prognostic value of osteopontin in patients with hepatocellular carcinoma
Tingting Sun, Peng Li, Diwen Sun, Qingao Bu, Guoqiang Li
Medicine.2018; 97(43): e12954. CrossRef Pilot Evaluation of Angiogenesis Signaling Factor Response after Transcatheter Arterial Embolization for Hepatocellular Carcinoma
James Ronald, Andrew B. Nixon, Daniele Marin, Rajan T. Gupta, Gemini Janas, Willa Chen, Paul V. Suhocki, Waleska Pabon-Ramos, David R. Sopko, Mark D. Starr, John C. Brady, Herbert I. Hurwitz, Charles Y. Kim
Radiology.2017; 285(1): 311. CrossRef Overexpression of osteopontin promotes resistance to cisplatin treatment in HCC
KUN DING, LU FAN, SHIJUN CHEN, YANNA WANG, HAIFENG YU, YANNI SUN, JIGUANG YU, LI WANG, XIANGZHONG LIU, YOUDE LIU
Oncology Reports.2015; 34(6): 3297. CrossRef Higher Matrix Stiffness Upregulates Osteopontin Expression in Hepatocellular Carcinoma Cells Mediated by Integrin β1/GSK3β/β-Catenin Signaling Pathway
Yang You, Qiongdan Zheng, Yinying Dong, Yaohui Wang, Lan Zhang, Tongchun Xue, Xiaoying Xie, Chao Hu, Zhiming Wang, Rongxin Chen, Yanhong Wang, Jiefeng Cui, Zhenggang Ren, David Wai Chan
PLOS ONE.2015; 10(8): e0134243. CrossRef Circulating biomarkers of hepatocellular carcinoma response after locoregional treatments: New insights
Maria Tampaki
World Journal of Hepatology.2015; 7(14): 1834. CrossRef Meta-Analysis of the Prognostic and Diagnostic Significance of Serum/Plasma Osteopontin in Hepatocellular Carcinoma
JiWen Cheng, WanLi Wang, CaiHong Sun, MuXing Li, Bo Wang, Yi Lv
Journal of Clinical Gastroenterology.2014; 48(9): 806. CrossRef Circulating markers for prognosis of hepatocellular carcinoma
Kwong-Fai Wong, Zhi Xu, Jinfei Chen, Nikki P Lee, John M Luk
Expert Opinion on Medical Diagnostics.2013; 7(4): 319. CrossRef Plasma Osteopontin Level as a Diagnostic Marker of Hepatocellular Carcinoma in Patients with Radiological Evidence of Focal Hepatic Lesions
Ashraf Khalil, Jamalat Elgedawy, Mohammed F Faramawi, Ashraf Elfert, Ibrahim Salama, Ahmed Abbass, Hala Elsaid, Hatem Elsebaai
Tumori Journal.2013; 99(1): 100. CrossRef Recurrence and Poor Prognosis Following Resection of Small Hepatitis B-Related Hepatocellular Carcinoma Lesions Are Associated with Aberrant Tumor Expression Profiles of Glypican 3 and Osteopontin
Ming-Chin Yu, Yun-Shien Lee, Sey-En Lin, Hsiang-Yao Wu, Tse-Ching Chen, Wei-Chen Lee, Miin-Fu Chen, Chi-Neu Tsai
Annals of Surgical Oncology.2012; 19(S3): 455. CrossRef Prognostic significance of osteopontin in hepatocellular carcinoma: A meta‐analysis
Chuan‐Hai Zhang, Ge‐Liang Xu, Wei‐Dong Jia, Yong‐Sheng Ge, Jian‐Sheng Li, Jin‐Liang Ma, Wei‐Hua Ren
International Journal of Cancer.2012; 130(11): 2685. CrossRef ATX–LPA Axis Induces Expression of OPN in Hepatic Cancer Cell SMMC7721
Rihua Zhang, Zhihong Zhang, Xiaolin Pan, Xiayue Huang, Zuhu Huang, Guoxin Zhang
The Anatomical Record.2011; 294(3): 406. CrossRef Osteopontin as a Key Mediator for Vasculogenic Mimicry in Hepatocellular Carcinoma
Wenbin Liu, Geliang Xu, Jinliang Ma, Weidong Jia, Jiansheng Li, Ke Chen, Wei Wang, Chen Hao, Yongcang Wang, Xiujun Wang
The Tohoku Journal of Experimental Medicine.2011; 224(1): 29. CrossRef Clinical Significance of Plasma Osteopontin Level in Egyptian Patients with Hepatitis C Virus-related Hepatocellular Carcinoma
Sahar Saad El-Din Bessa, Nadia Mohamed Elwan, Ghada Abdul Moemen Suliman, Safinaz Hamdy El-Shourbagy
Archives of Medical Research.2010; 41(7): 541. CrossRef
|